Latest Regulatory Risk News

Page 2 of 35
Antilles Gold remains largely stalled in Cuba after its joint venture was designated a US Specially Designated National, with only site security continuing at Nueva Sabana. A conditional GEM deal could bring US$18 million and a path towards sanction relief, but the company ended September with just US$882,000 in cash.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Raiz Invest delivered solid Q1 FY27 growth, with funds under management rising 20.2% to $2.40 billion and customer numbers reaching 354,202. But the fintech still cannot reliably quantify the potential impact of historical tax matters now under expert and regulatory review.
Claire Turing
Claire Turing
30 Oct 2026
Resonance Health has secured an oversubscribed $6.0 million placement to fund MRI endpoint expansion, new TrialsWest sites and development of its non-invasive liver fibrosis device. The raise lifts pro forma net cash to $7.9 million, but the most consequential project remains an investigational technology backed by a small preliminary dataset.
Victor Sage
Victor Sage
27 Oct 2026
Clarity Pharmaceuticals has completed planned recruitment for its 383-participant CLARIFY Phase III trial of 64Cu-SAR-bisPSMA, moving the diagnostic candidate into patient follow-up. Topline sensitivity and specificity data are expected in the first half of 2027 and could support a US FDA application.
Ada Torres
Ada Torres
27 Oct 2026
AdAlta is nearing two important development milestones for its EW-001 CAR-T therapy, with a US FDA pre-IND meeting scheduled for 4 November and Australian manufacturing runs expected before year-end. The progress comes with encouraging but early Chinese clinical data, while cash of A$0.65 million leaves limited room for delay.
Ada Torres
Ada Torres
26 Oct 2026
EQT Holdings delivered strong growth from its continuing businesses in FY26, but a superannuation exit, litigation and takeover uncertainty left group profit and dividends lower. The company says discussions with BGH Capital and TPG Global remain open, while targeting completion of the superannuation exit by the end of 2027.
Claire Turing
Claire Turing
21 Oct 2026
Dusk Group has carried its FY26 momentum into the new financial year, with like-for-like sales up 7.2% in the first 15 weeks despite operating six fewer stores. The home-fragrance retailer is now preparing a tightly controlled South African launch while an unresolved ACCC court case remains a material complication.
Logan Eniac
Logan Eniac
16 Oct 2026
Adveritas has secured a $2 million placement at a 42.9% premium to its last close, with the proceeds earmarked for product development, marketing and working capital. The funding comes as the company pushes beyond sports betting and gaming while managing delayed Brazilian customer payments.
Sophie Babbage
Sophie Babbage
15 Oct 2026
WiseTech Global’s FY26 annual report charts a year of extraordinary expansion, with revenue up 79% after the e2open acquisition and underlying EBITDA up 56%. But the stronger earnings base comes with heavier debt, a major workforce reset and unresolved regulatory risks.
Sophie Babbage
Sophie Babbage
13 Oct 2026
AXP Energy has launched a 1-for-1 non-renounceable entitlement offer seeking between A$1.2 million and A$2.249 million. The funding could support Oklahoma development, but the prospectus also highlights material going-concern uncertainty, creditor dependence and significant dilution for shareholders who do not participate.
Victor Sage
Victor Sage
12 Oct 2026
DPM Metals produced 97,000 gold equivalent ounces in the third quarter and now expects to reach the high end of its 2026 production guidance. Vareš is running ahead of expectations, but its growth plans remain exposed to an unresolved legal review in Bosnia and Herzegovina.
Maxwell Dee
Maxwell Dee
9 Oct 2026
Aurum Resources has confirmed that the Boundiali assay information was market-sensitive, while defending the timing and validity of a cleansing notice issued before the results were released. ASX has not indicated whether it accepts the company’s explanation.
Maxwell Dee
Maxwell Dee
7 Oct 2026

Browse the archive

Full archive